APOTHEEK LEFEVER - BROERS
APOTHEEK LEFEVER - BROERS has been active since 1978 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €695k and a net result of €102k. Equity remains stable across the filed fiscal years (±1.5% per year). Its solvency ranks better than 91% of 480 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).
| Equity | €695k |
| Net result | €102k |
| Staff (FTE) | 1 |
| Better than sector | 91% |
Exceptional profile, strong across almost every axis.
All 5 axes are computed from data Checked has read.
The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 80.0% | 21.2% | |
| Net result | €102k | €32k | |
| Equity | €695k | €163k | |
| Gross operating margin | €217k | €281k | |
| Staff costs | €38k | €211k |
Figures by fiscal year and ratios
| Fiscal year | 2025 |
|---|---|
| Deposit | abbreviated schema |
| Revenue | - |
| EBITDA | €176k |
| Net profit | €102k |
| Cash flow | €145k |
| Staff costs | €38k |
| Income taxes | €30k |
| Dividends | €84k |
| Total assets | €868k |
| Equity | €695k |
| Debt | €173k |
| of which ≤ 1y | €171k |
| of which > 1y | - |
| Working capital | €563k |
| Employees (FTE) | 1.0 |
| 2025 | |
|---|---|
| Current ratio | 4.30 |
| Quick ratio | 3.10 |
| Working capital ratio | 64.9% |
| Solvency | 80.0% |
| Debt / equity | 0.25 |
| Long-term debt ratio | - |
| Interest coverage | 66.92 |
| Gross margin | - |
| Net margin | - |
| ROA | 11.8% |
| ROE | 14.7% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
Full annual accounts (24 line items)
| Line item | Code | 2025 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €868k |
| Fixed assets | 21/28 | €134k |
| Tangible fixed assets | 22/27 | €134k |
| Current assets | 29/58 | €734k |
| Stocks & contracts in progress | 3 | €204k |
| Amounts receivable within one year | 40/41 | €85k |
| Investments | 50/53 | €287k |
| Cash & bank | 54/58 | €126k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €868k |
| Equity | 10/15 | €695k |
| Contributions / capital | 10/11 | €19k |
| Reserves | 13 | €676k |
| Accumulated profits (losses) | 14 | €0 |
| Amounts payable | 17/49 | €173k |
| Amounts payable within one year | 42/48 | €171k |
| Trade debts payable within one year | 44 | €83k |
| Income statement | ||
| Gross operating margin | 9900 | €217k |
| Operating result | 9901 | €134k |
| Financial income | 75 | €1k |
| Financial charges | 65 | €3k |
| Result before taxes | 9903 | €132k |
| Income taxes | 67/77 | €30k |
| Net result for the period | 9904 | €102k |
| Result to be appropriated | 9905 | €102k |
| NACE primary | Retail sale of pharmaceutical products(47730) |
| Legal form | Private limited company(610) |
| Incorporation | 01-01-1978 |
| Status | Active |
| Postal code | 2990 |
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11053D0752/00B002 | Flanders | 1,969 m² | 1 · 230 m² | 12.0 m · 2 fl. |
10-06-2026 NBB filing Annual accounts filed
29-08-2025 NBB filing Annual accounts filed
30-08-2024 NBB filing Annual accounts filed
19-07-2023 NBB filing Annual accounts filed
20-04-2023 State Gazette act Director changes
28-07-2022 NBB filing Annual accounts filed
27-07-2021 NBB filing Annual accounts filed
30-07-2020 NBB filing Annual accounts filed
24-06-2019 NBB filing Annual accounts filed
24-08-2018 NBB filing Annual accounts filed
23-08-2017 NBB filing Annual accounts filed
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
20-04-2023 Board composition published
Technical details
{
"events": [
{
"kind": "substantive_delegation",
"role": "dagelijks_bestuur",
"person": null,
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "CVBA Vandelanotte Accountancy",
"address": null,
"country": null,
"legal_form": "CVBA"
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "De vergadering machtigde CVBA Vandelanotte Accountancy en hun aangestelden en gevolmachtigden, met mogelijkheid tot indeplaatsstelling, en die elk afzonderlijk kunnen handelen, om zowel naar aanleiding van deze als vroegere of toekomstige akten, alle formaliteiten te vervullen bij de kruispuntbank v",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "board_snapshot",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "LEFEVER Tm Christine Emile",
"address": "2990 Wuustwezel, Dorpsstraat 17",
"birth_date": "1963-02-17",
"profession": null,
"birth_place": "Merksem"
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": "statutair",
"compensated": null,
"effective_date": null,
"evidence_quote": "De vergadering beslist daarop de nagemelde huidige bestuurders, voor zoveel als nodig te bevestigen in hun benoeming als statutaire bestuurders van de vennootschap en dit voor onbepaalde duur:",
"decharge_status": null,
"mandate_duration": {
"kind": "indefinite",
"value": null
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "board_snapshot",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "BROERS Dominica Luc Maria",
"address": "2990 Wuustwezel, Dorpsstraat 17",
"birth_date": "1964-01-10",
"profession": null,
"birth_place": "Geel"
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": "statutair",
"compensated": null,
"effective_date": null,
"evidence_quote": "De vergadering beslist daarop de nagemelde huidige bestuurders, voor zoveel als nodig te bevestigen in hun benoeming als statutaire bestuurders van de vennootschap en dit voor onbepaalde duur:",
"decharge_status": null,
"mandate_duration": {
"kind": "indefinite",
"value": null
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": "Luc Dejongh",
"firm_city": null,
"firm_name": null,
"office_city": "Kalmthout",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2023-04-20",
"filing_date": "2023-04-18",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "algemene_vergadering",
"date": "2023-04-11",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0418.123.844",
"name_full": "APOTHEEK LEFEVER - BROERS",
"legal_form": "BV"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Luc Dejongh",
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"uitgifte met geco\u00F6rdineerde statuten"
],
"corrected_publication_numac": null
}| Legal nameNL | APOTHEEK LEFEVER - BROERS |